StockData

Vanda Pharmaceuticals Inc. (VNDA) stock

VNDANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 10/3055% below fair value
$3.75−0.06 (-1.57%)

Close on Nov 18, 2026Market cap $226.76MP/E –Yield –

Vanda Pharmaceuticals price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Vanda Pharmaceuticals's price to book ratio was 1.1× on Nov 11, 2026, against 0.7× a year earlier. Over the last 5 years it ranged from 0.4× to 1.8×, with a median of 0.7×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.1×+0.0
2025Dec 31, 20251.1×+0.6
2024Dec 31, 20240.5×+0.1
2023Dec 29, 20230.4×−0.4
2022Dec 30, 20220.8×−1.0
2021Dec 31, 20211.8×+0.1
2020Dec 31, 20201.6×−0.6
2019Dec 31, 20192.2×−3.1
2018Dec 31, 20185.2×+0.0
2017Dec 29, 20175.2×−0.2
2016Dec 30, 20165.4×+2.7
2015Dec 31, 20152.7×−454.0
2014Dec 31, 2014456.7×+448.5
2013Dec 31, 20138.2×+1.4
2012Dec 31, 20126.8×+3.3
2011Dec 30, 20113.6×−7.5
2010Dec 31, 201011.1×–

More Vanda Pharmaceuticals figures

See a number that looks wrong?